Skye Bioscience, Inc.
SKYESkye Bioscience, Inc.
NASDAQ
Healthcare
Biotechnology
$0.66
-0.01(-1.3%)
52W $0.58 – $4.75
Quick:
8-K
Apr 3, 2026 (3 days ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 19, 2026 (2 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 10, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 10, 2026 (3 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Feb 20, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 2, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 23, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Dec 16, 2025 (3 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
10-Q
Nov 10, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 10, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 6, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Aug 7, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 7, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Jun 11, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
May 15, 2025 (10 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
May 8, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 8, 2025 (11 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G/A
Apr 10, 2025 (12 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-K
Mar 20, 2025 (1 years ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures